Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinicnews2026-09-09T11:00:54+00:00September 9th, 2026|Endpoints News|
Kura Oncology spins out diabetes pipeline with $50M and Lilly’s helpnews2026-09-09T11:00:49+00:00September 9th, 2026|Endpoints News|
Moonwalk raises $70M to test siRNA treatment for obesitynews2026-09-08T12:00:17+00:00September 8th, 2026|Endpoints News|
BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-Tnews2026-09-08T11:00:53+00:00September 8th, 2026|Endpoints News|
Claret says its latest fund will have larger focus on European life sciences news2026-09-07T05:00:06+00:00September 7th, 2026|Endpoints News|
US-China biotech NeuShen gets $80M to develop brain-health drugsnews2026-09-04T14:47:16+00:00September 4th, 2026|Endpoints News|
Superluminal secures $60M for Phase 1 of genetic obesity drugnews2026-09-03T10:00:59+00:00September 3rd, 2026|Endpoints News|
Typewriter raises $56M for jumping gene technology and in vivo CAR-T therapiesnews2026-09-02T11:00:57+00:00September 2nd, 2026|Endpoints News|
ARCH Venture Partners targets $3 billion raise for latest fundnews2026-09-01T00:55:30+00:00September 1st, 2026|Endpoints News|
Abcuro gets $66M for Phase 3 in muscle-weakening conditionnews2026-08-14T15:28:46+00:00August 14th, 2026|Endpoints News|
